Artificial Intelligence & Data
Rewrite Therapeutics
United Statesrewritetherapeutics.com
Rewrite Therapeutics is an Artificial Intelligence & Data startup based in the United States, since acquired, 1 tracked investor.
acquired
acquired
Stage
1
Investors
About Rewrite Therapeutics
Based in the United States, Rewrite Therapeutics is a startup. Rewrite Therapeutics has been acquired. Brouky classifies it under Artificial Intelligence & Data. Brouky records 1 investor associated with the company.
Rewrite Therapeutics is a UC Berkeley spinout developing CRISPR-guided DNA polymerization technology that enables genome editing without double-strand breaks, particularly targeting challenges in editing non-dividing cell types.
Explore Rewrite Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.